+987.9%
MRNA vs HST
+76.4%
+911.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HST | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +1.3% | +11.8% | +11.8% |
| 7D | +20.6% | +3.3% | +17.3% | +16.8% |
| 30D | +27.1% | +16.4% | +10.8% | +9.6% |
| 3M | +353.4% | +5.5% | +347.9% | +325.3% |
| 6M | +446.3% | +31.1% | +415.1% | +318.8% |
| YTD | +776.2% | +55.9% | +720.2% | +469.5% |
| 1Y | +987.9% | +75.6% | +912.3% | +546.5% |
| All | +987.9% | +76.4% | +911.5% | +546.5% |
Cumulative growth
Daily Returns
Daily percentage return beside HST.
Daily Out/Under-Performance
Portfolio return minus HST return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HST return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HST wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling